Back

Cardiotoxicity in multiple myeloma patients in Hong Kong: a single-centre experience in the past decade

13 May 2024 (09:45 - 09:54)
Organised by: Logo
Congress Presentation Part of: How to improve prognosis in cardio-oncology Cardio-Oncology HFA Premium Access Heart Failure 2024 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Mei Han Ho

Queen Elizabeth Hospital, Hong Kong (Hong Kong)

4 More presentations in this session

Presentation thumbnail
The predictive value of routine troponin measurements in patients treated with immune checkpoint inhibitors
Doctor M. Laufer-Perl (Tel Aviv, IL)
Abstract Slides Video
Presentation thumbnail
Inherited cardiovascular disease mindset at cardio-oncology screening
Doctor R. Lorca (Oviedo, ES)
Abstract Slides Video
Presentation thumbnail
Soluble guanylate cyclase activator vericiguat prevents anthracycline-mediated cardiotoxicity and sarcopenia through NO-sGC-cGMP-NLRP3 pathway
Doctor N. Maurea (Naples, IT)
Abstract Slides Video
Presentation thumbnail
Fluoropyrimidine chemotherapy and the risk of death and cardiovascular events in patients with gastrointestinal cancer: a cohort study
Doctor A. Abiodun (London, GB)
Abstract Slides Video

Access the full session

Session thumbnail
How to improve prognosis in cardio-oncology
Video

The Event

Event poster

Heart Failure 2024

13 May 2024 09:45 CET
You may be interested in
thumbnail
Congress Session
How to improve prognosis in cardio-oncology
thumbnail
Congress Presentation
Integrating cardio-oncology in Multiple Myeloma: risk stratification and management of therapy-related cardiovascular toxicity
thumbnail
Congress Session
Daily cardiac problems in cancer patients

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources